{
  "guideline": {
    "id": "PA166104937",
    "name": "Annotation of DPWG Guideline for aripiprazole and CYP2D6",
    "objCls": "Guideline Annotation",
    "source": "DPWG",
    "version": 41,
    "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166104937",
    "relatedChemicals": [
      {
        "id": "PA10026",
        "name": "aripiprazole",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA128",
        "name": "cytochrome P450 family 2 subfamily D member 6",
        "symbol": "CYP2D6"
      }
    ],
    "recommendation": true
  },
  "recommendations": [
    {
      "id": "PA166301981",
      "name": "Recommendation Annotation PA166301981",
      "population": null,
      "classification": {
        "term": "No recommendation",
        "termId": "guidelineStrength:1448526251"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103500,
        "html": "<p>The guideline does not provide a recommendation for aripiprazole in normal metabolizers.</p>\n"
      },
      "implications": [
        "The guideline does not provide a description of the impact of a normal metabolizer phenotype on aripiprazole."
      ],
      "lookupKey": {
        "CYP2D6": "2.25"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301980",
      "name": "Recommendation Annotation PA166301980",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103499,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation decreases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is no evidence that this increases the risk of reduced effectiveness."
      ],
      "lookupKey": {
        "CYP2D6": "≥3.25"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301976",
      "name": "Recommendation Annotation PA166301976",
      "population": null,
      "classification": {
        "term": "No recommendation",
        "termId": "guidelineStrength:1448526251"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103495,
        "html": "<p>The guideline does not provide a recommendation for aripiprazole in normal metabolizers.</p>\n"
      },
      "implications": [
        "The guideline does not provide a description of the impact of a normal metabolizer phenotype on aripiprazole."
      ],
      "lookupKey": {
        "CYP2D6": "2.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301972",
      "name": "Recommendation Annotation PA166301972",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103491,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation increases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is insufficient evidence that this increases the risk of side effects."
      ],
      "lookupKey": {
        "CYP2D6": "0.75"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302003",
      "name": "Recommendation Annotation PA166302003",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103522,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation decreases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is no evidence that this increases the risk of reduced effectiveness."
      ],
      "lookupKey": {
        "CYP2D6": "≥6.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301975",
      "name": "Recommendation Annotation PA166301975",
      "population": null,
      "classification": {
        "term": "No recommendation",
        "termId": "guidelineStrength:1448526251"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103494,
        "html": "<p>The guideline does not provide a recommendation for aripiprazole in normal metabolizers.</p>\n"
      },
      "implications": [
        "The guideline does not provide a description of the impact of a normal metabolizer phenotype on aripiprazole."
      ],
      "lookupKey": {
        "CYP2D6": "1.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301971",
      "name": "Recommendation Annotation PA166301971",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103490,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation increases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is insufficient evidence that this increases the risk of side effects."
      ],
      "lookupKey": {
        "CYP2D6": "0.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301970",
      "name": "Recommendation Annotation PA166301970",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103489,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation increases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is insufficient evidence that this increases the risk of side effects."
      ],
      "lookupKey": {
        "CYP2D6": "0.25"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301979",
      "name": "Recommendation Annotation PA166301979",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103498,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation decreases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is no evidence that this increases the risk of reduced effectiveness."
      ],
      "lookupKey": {
        "CYP2D6": "4.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302002",
      "name": "Recommendation Annotation PA166302002",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103521,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation decreases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is no evidence that this increases the risk of reduced effectiveness."
      ],
      "lookupKey": {
        "CYP2D6": "≥5.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301978",
      "name": "Recommendation Annotation PA166301978",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103497,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation decreases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is no evidence that this increases the risk of reduced effectiveness."
      ],
      "lookupKey": {
        "CYP2D6": "3.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301974",
      "name": "Recommendation Annotation PA166301974",
      "population": null,
      "classification": {
        "term": "No recommendation",
        "termId": "guidelineStrength:1448526251"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103493,
        "html": "<p>The guideline does not provide a recommendation for aripiprazole in normal metabolizers.</p>\n"
      },
      "implications": [
        "The guideline does not provide a description of the impact of a normal metabolizer phenotype on aripiprazole."
      ],
      "lookupKey": {
        "CYP2D6": "1.25"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301983",
      "name": "Recommendation Annotation PA166301983",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103502,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation decreases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is no evidence that this increases the risk of reduced effectiveness."
      ],
      "lookupKey": {
        "CYP2D6": "≥3.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301982",
      "name": "Recommendation Annotation PA166301982",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103501,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation decreases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is no evidence that this increases the risk of reduced effectiveness."
      ],
      "lookupKey": {
        "CYP2D6": "≥3.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301969",
      "name": "Recommendation Annotation PA166301969",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103488,
        "html": "<p>Administer no more than 10 mg/day or 300 mg/month (68-75% of the normal maximum dose of aripiprazole).</p>\n"
      },
      "implications": [
        "The risk of side effects is increased. The genetic variation leads to an increase in the sum of the plasma concentrations of aripiprazole and the active metabolite."
      ],
      "lookupKey": {
        "CYP2D6": "0.0"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302001",
      "name": "Recommendation Annotation PA166302001",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103520,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation decreases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is no evidence that this increases the risk of reduced effectiveness."
      ],
      "lookupKey": {
        "CYP2D6": "≥4.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301977",
      "name": "Recommendation Annotation PA166301977",
      "population": null,
      "classification": {
        "term": "No recommendation",
        "termId": "guidelineStrength:1448526251"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103496,
        "html": "<p>The guideline does not provide a recommendation for aripiprazole in normal metabolizers.</p>\n"
      },
      "implications": [
        "The guideline does not provide a description of the impact of a normal metabolizer phenotype on aripiprazole."
      ],
      "lookupKey": {
        "CYP2D6": "2.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166301973",
      "name": "Recommendation Annotation PA166301973",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA10026",
          "name": "aripiprazole",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452103492,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation increases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is insufficient evidence that this increases the risk of side effects."
      ],
      "lookupKey": {
        "CYP2D6": "1.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [
    {
      "pmid": "37002327",
      "title": "Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.",
      "authors": [
        "Beunk Lianne",
        "Nijenhuis Marga",
        "Soree Bianca",
        "de Boer-Veger Nienke J",
        "Buunk Anne-Marie",
        "Guchelaar Henk Jan",
        "Houwink Elisa J F",
        "Risselada Arne",
        "Rongen Gerard A P J M",
        "van Schaik Ron H N",
        "Swen Jesse J",
        "Touw Daan",
        "van Westrhenen Roos",
        "Deneer Vera H M",
        "van der Weide Jan"
      ],
      "journal": "European journal of human genetics : EJHG",
      "year": 2023,
      "_sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/37002327"
    },
    {
      "pmid": "21412232",
      "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
      "authors": [
        "Swen J J",
        "Nijenhuis M",
        "de Boer A",
        "Grandia L",
        "Maitland-van der Zee A H",
        "Mulder H",
        "Rongen G A P J M",
        "van Schaik R H N",
        "Schalekamp T",
        "Touw D J",
        "van der Weide J",
        "Wilffert B",
        "Deneer V H M",
        "Guchelaar H-J"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2011,
      "_sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/21412232"
    }
  ],
  "version": "2024-03-08-14-34"
}